Skip to main content

Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice.

J Womens Health Gend Based Med. 2002 Apr;11(3):291-301.
J Womens Health Gend Based Med. 2002 Apr;11(3):291-301.
Nitin Rohatgi
Nitin Rohatgi
Principal investigator
View Profile

Research Topics

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?